Market Cap ₹7739 Cr.
Stock P/E -48.8
P/B 2.8
Current Price ₹489.5
Book Value ₹ 176.6
Face Value 5
52W High ₹633
Dividend Yield 0%
52W Low ₹ 413.8
Chemplast Sanmar Ltd manufactures and markets speciality chemical compounds in India. The company offers speciality paste PVC resin; custom manufactured chemicals, consisting of natural chemical compounds, and phyto chemical compounds comprising colchicine and thiocolchicoside; chlorochemicals, together with caustic chlor, solvents, and refrigerant gas; and hydrogen peroxide. It offers strong point paste PVC resin and custom synthetic chemical compounds for agro-chemical, pharmaceutical, and high-quality chemicals sectors. The organisation was previously referred to as Chemicals and Plastics India Ltd and changed its name to Chemplast Sanmar Ltd in September 1995. The business enterprise was established in 1967 and is primarily based in Chennai, India. Chemplast Sanmar Ltd is a subsidiary of Sanmar Holdings Ltd.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 | Mar 2012 |
---|---|---|---|---|---|---|---|---|
Net Sales | 405 | 498 | 444 | 576 | 519 | 561 | 518 | 533 |
Other Income | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 6 |
Total Income | 405 | 498 | 444 | 581 | 519 | 561 | 518 | 539 |
Total Expenditure | 377 | 449 | 401 | 519 | 452 | 514 | 480 | 510 |
Operating Profit | 27 | 50 | 44 | 62 | 67 | 48 | 38 | 29 |
Interest | 40 | 39 | 40 | 38 | 42 | 43 | 37 | 37 |
Depreciation | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 24 |
Exceptional Income / Expenses | 0 | 0 | 0 | 11 | 0 | 0 | 0 | 0 |
Profit Before Tax | -36 | -12 | -19 | 11 | 2 | -18 | -22 | -31 |
Provision for Tax | -14 | 0 | -5 | 5 | 0 | -5 | -8 | -6 |
Profit After Tax | -22 | -13 | -14 | 6 | 2 | -13 | -15 | -26 |
Adjustments | 22 | 13 | 14 | -6 | -2 | 13 | 15 | 26 |
Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Adjusted Earnings Per Share | -1.4 | -0.8 | -0.9 | 0.4 | 0.1 | -0.8 | -0.9 | -1.6 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2645 | 2643 | 2493 | 2903 | 3030 | 1253 | 1259 | 1289 | 2012 | 2197 | 1656 | 2131 |
Other Income | 32 | 27 | 20 | 29 | 22 | 17 | 8 | 6 | 33 | 26 | 42 | 6 |
Total Income | 2678 | 2670 | 2513 | 2932 | 3052 | 1270 | 1267 | 1295 | 2045 | 2222 | 1697 | 2137 |
Total Expenditure | 2428 | 2485 | 2143 | 2424 | 2506 | 935 | 945 | 898 | 1385 | 1891 | 1714 | 1956 |
Operating Profit | 249 | 185 | 370 | 508 | 546 | 334 | 322 | 397 | 660 | 332 | -17 | 182 |
Interest | 167 | 163 | 163 | 73 | 77 | 47 | 95 | 254 | 136 | 23 | 33 | 159 |
Depreciation | 91 | 57 | 65 | 69 | 75 | 55 | 87 | 88 | 91 | 92 | 107 | 93 |
Exceptional Income / Expenses | 0 | 0 | 0 | -49 | -28 | 15 | 0 | -16 | 0 | -50 | 0 | 0 |
Profit Before Tax | -9 | -35 | 143 | 318 | 366 | 248 | 139 | 40 | 434 | 167 | -156 | -69 |
Provision for Tax | -2 | -10 | 61 | 168 | 187 | 60 | 40 | -4 | 54 | 21 | -52 | -19 |
Profit After Tax | -8 | -25 | 82 | 150 | 179 | 187 | 99 | 44 | 379 | 146 | -104 | -52 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 52 |
Profit After Adjustments | -8 | -25 | 82 | 150 | 179 | 187 | 99 | 44 | 379 | 146 | -104 | 0 |
Adjusted Earnings Per Share | -0.5 | -1.6 | 5.1 | 9.4 | 11.2 | 14 | 7.4 | 3.3 | 24 | 9.2 | -6.6 | -3.2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -25% | 9% | 6% | -5% |
Operating Profit CAGR | -105% | NAN% | NAN% | NAN% |
PAT CAGR | -171% | NAN% | NAN% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 10% | -9% | NA% | NA% |
ROE Average | -4% | 7% | 8% | 18% |
ROCE Average | -4% | 9% | 10% | 21% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 252 | 224 | 306 | 317 | 496 | 1879 | 1977 | 2021 | 3797 | 3944 | 3840 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 172 | 379 | 299 | 232 | 170 | 677 | 1207 | 1184 | 0 | 204 | 499 |
Other Non-Current Liabilities | -45 | -68 | -12 | 136 | 336 | 574 | 595 | 582 | 612 | 584 | 528 |
Total Current Liabilities | 1394 | 1417 | 1326 | 1587 | 1629 | 690 | 428 | 497 | 544 | 763 | 962 |
Total Liabilities | 1773 | 1953 | 1918 | 2272 | 2631 | 3820 | 4206 | 4284 | 4954 | 5494 | 5830 |
Fixed Assets | 1206 | 1154 | 1107 | 1067 | 1016 | 2087 | 2175 | 2103 | 2233 | 2200 | 2929 |
Other Non-Current Assets | 26 | 36 | 32 | 55 | 110 | 159 | 1589 | 1605 | 1625 | 2014 | 1793 |
Total Current Assets | 540 | 760 | 777 | 1150 | 1505 | 1574 | 443 | 556 | 1097 | 1280 | 1108 |
Total Assets | 1773 | 1953 | 1918 | 2272 | 2631 | 3820 | 4206 | 4284 | 4954 | 5494 | 5830 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 73 | 45 | 341 | 158 | 62 | 129 | 49 | 75 | 74 | 357 | 512 |
Cash Flow from Operating Activities | 575 | 113 | 176 | 642 | 445 | 232 | 166 | 411 | 430 | 271 | -98 |
Cash Flow from Investing Activities | -14 | 5 | -247 | -388 | -370 | -311 | -438 | -80 | -51 | -286 | -537 |
Cash Flow from Financing Activities | -589 | 178 | -113 | -350 | 16 | -1 | 298 | -333 | -96 | 171 | 406 |
Net Cash Inflow / Outflow | -27 | 296 | -183 | -96 | 91 | -80 | 26 | -1 | 283 | 155 | -230 |
Closing Cash & Cash Equivalent | 45 | 341 | 158 | 62 | 153 | 49 | 75 | 74 | 357 | 512 | 283 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -0.49 | -1.59 | 5.12 | 9.39 | 11.16 | 13.96 | 7.36 | 3.25 | 24 | 9.21 | -6.57 |
CEPS(Rs) | 0 | 0 | 9.18 | 13.68 | 15.87 | 18.06 | 13.88 | 9.8 | 29.74 | 15.05 | 0.18 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 7.88 | 6 | 11.17 | 19.83 | 30.99 | 58.96 | 67.89 | 72.81 | 168.18 | 178.99 | 174.34 |
Core EBITDA Margin(%) | 7.32 | 5.34 | 12.52 | 14.7 | 16.41 | 25.19 | 24.81 | 30.35 | 31.19 | 13.92 | -3.53 |
EBIT Margin(%) | 5.32 | 4.31 | 10.91 | 11.99 | 13.89 | 23.4 | 18.52 | 22.78 | 28.3 | 8.62 | -7.46 |
Pre Tax Margin(%) | -0.32 | -1.19 | 5.1 | 9.76 | 11.46 | 19.66 | 10.98 | 3.1 | 21.55 | 7.59 | -9.43 |
PAT Margin (%) | -0.27 | -0.86 | 2.93 | 4.61 | 5.6 | 14.87 | 7.8 | 3.39 | 18.86 | 6.63 | -6.27 |
Cash Profit Margin (%) | 2.82 | 1.07 | 5.25 | 6.71 | 7.96 | 19.23 | 14.71 | 10.19 | 23.37 | 10.83 | 0.17 |
ROA(%) | -0.44 | -1.37 | 4.23 | 7.17 | 7.29 | 5.8 | 2.46 | 1.03 | 8.22 | 2.79 | -1.83 |
ROE(%) | -6.08 | -22.97 | 59.6 | 60.57 | 43.93 | 29.11 | 11.61 | 4.63 | 20.88 | 5.3 | -3.72 |
ROCE(%) | 19.6 | 17.09 | 31.48 | 43.96 | 50.21 | 21.82 | 12.08 | 13.38 | 23.49 | 6.65 | -3.83 |
Receivable days | 14.12 | 14.98 | 11.84 | 8.35 | 7.65 | 18.42 | 16.6 | 16.45 | 22.53 | 36.26 | 48.35 |
Inventory Days | 23.12 | 21.69 | 21.84 | 28.36 | 36.78 | 74.42 | 55.1 | 59.35 | 52.99 | 61.44 | 85.35 |
Payable days | 202.67 | 217.92 | 207.47 | 191.06 | 200.9 | 534.76 | 188.7 | 224.66 | 180.88 | 178.14 | 250.25 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.69 | 37.69 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.95 | 1.94 | 2.56 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.14 | 0.16 | 0.26 | 0.15 | 0.15 | 0.72 | 0.99 | 0.88 | 4.99 | 2.35 | 4.48 |
EV/Core EBITDA(x) | 1.5 | 2.28 | 1.76 | 0.88 | 0.82 | 2.71 | 3.86 | 2.85 | 15.2 | 15.58 | -443.25 |
Net Sales Growth(%) | 17.92 | -0.07 | -5.69 | 16.45 | 4.37 | -58.65 | 0.53 | 2.34 | 56.13 | 9.17 | -24.63 |
EBIT Growth(%) | -2.48 | -19.08 | 138.93 | 28.08 | 13.23 | -33.48 | -20.42 | 25.23 | 93.96 | -66.75 | -165.21 |
PAT Growth(%) | -165.86 | -223.89 | 421.15 | 83.48 | 18.88 | 4.82 | -47.26 | -55.82 | 769.83 | -61.64 | -171.35 |
EPS Growth(%) | -165.84 | -223.89 | 421.15 | 83.48 | 18.88 | 25.08 | -47.26 | -55.82 | 637.58 | -61.64 | -171.35 |
Debt/Equity(x) | 2.7 | 7.12 | 4.09 | 1.35 | 1.06 | 1.13 | 1.42 | 1.24 | 0 | 0.07 | 0.24 |
Current Ratio(x) | 0.39 | 0.54 | 0.59 | 0.72 | 0.92 | 2.28 | 1.03 | 1.12 | 2.01 | 1.68 | 1.15 |
Quick Ratio(x) | 0.25 | 0.43 | 0.45 | 0.52 | 0.73 | 1.99 | 0.61 | 0.64 | 1.38 | 1.16 | 0.75 |
Interest Cover(x) | 0.94 | 0.78 | 1.88 | 5.39 | 5.73 | 6.27 | 2.46 | 1.16 | 4.19 | 8.36 | -3.78 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.09 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 |
FII | 8.56 | 7.62 | 7.75 | 7.41 | 11.46 | 11.6 | 11.16 | 10.83 | 11.27 | 13.41 |
DII | 26.98 | 26.46 | 26.81 | 27.81 | 26.64 | 26.93 | 27.51 | 28.15 | 28.39 | 25.74 |
Public | 9.47 | 10.93 | 10.45 | 9.79 | 6.91 | 6.48 | 6.34 | 6.03 | 5.35 | 5.85 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 |
FII | 1.35 | 1.2 | 1.23 | 1.17 | 1.81 | 1.83 | 1.76 | 1.71 | 1.78 | 2.12 |
DII | 4.27 | 4.18 | 4.24 | 4.4 | 4.21 | 4.26 | 4.35 | 4.45 | 4.49 | 4.07 |
Public | 1.5 | 1.73 | 1.65 | 1.55 | 1.09 | 1.02 | 1 | 0.95 | 0.85 | 0.93 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About